Chowdhury K, Holden M, Wiley M, Suppiramaniam V, Reed M
Cells. 2024; 13(13.
PMID: 38994982
PMC: 11240741.
DOI: 10.3390/cells13131130.
Blanton H, Reddy P, Benamar K
Exp Neurol. 2022; 360:114287.
PMID: 36455638
PMC: 9789196.
DOI: 10.1016/j.expneurol.2022.114287.
Reid H, Snowden T, Shkolnikov I, Breit K, Rodriguez C, Thomas J
Alcohol Clin Exp Res. 2021; 45(11):2246-2255.
PMID: 34523142
PMC: 8642289.
DOI: 10.1111/acer.14708.
Abate G, Uberti D, Tambaro S
Biology (Basel). 2021; 10(6).
PMID: 34204237
PMC: 8234911.
DOI: 10.3390/biology10060542.
Yeung A, Tzvetkov N, Arkells N, Milella L, Stankiewicz A, Huminiecki L
J Cannabis Res. 2021; 1(1):4.
PMID: 33526099
PMC: 7815052.
DOI: 10.1186/s42238-019-0004-y.
Impairment of Synaptic Plasticity by Cannabis, Δ-THC, and Synthetic Cannabinoids.
Hoffman A, Hwang E, Lupica C
Cold Spring Harb Perspect Med. 2020; 11(5).
PMID: 32341064
PMC: 8091957.
DOI: 10.1101/cshperspect.a039743.
A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations.
Blest-Hopley G, Giampietro V, Bhattacharyya S
Brain Sci. 2020; 10(2).
PMID: 32069958
PMC: 7071506.
DOI: 10.3390/brainsci10020102.
The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.
Cohen K, Weinstein A
Brain Sci. 2018; 8(3).
PMID: 29495540
PMC: 5870358.
DOI: 10.3390/brainsci8030040.
The effects of synthetic cannabinoids on executive function.
Cohen K, Kapitany-Foveny M, Mama Y, Arieli M, Rosca P, Demetrovics Z
Psychopharmacology (Berl). 2017; 234(7):1121-1134.
PMID: 28160034
DOI: 10.1007/s00213-017-4546-4.
Molecular mechanisms underlying activity-dependent AMPA receptor cycling in retinal ganglion cells.
Casimiro T, Nawy S, Carroll R
Mol Cell Neurosci. 2013; 56:384-92.
PMID: 23911793
PMC: 3809769.
DOI: 10.1016/j.mcn.2013.07.010.
Synergistic Effect between Maternal Infection and Adolescent Cannabinoid Exposure on Serotonin 5HT1A Receptor Binding in the Hippocampus: Testing the "Two Hit" Hypothesis for the Development of Schizophrenia.
Dalton V, Verdurand M, Walker A, Hodgson D, Zavitsanou K
ISRN Psychiatry. 2013; 2012:451865.
PMID: 23738203
PMC: 3658855.
DOI: 10.5402/2012/451865.
Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats.
Abush H, Akirav I
PLoS One. 2012; 7(2):e31731.
PMID: 22348124
PMC: 3278466.
DOI: 10.1371/journal.pone.0031731.
Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
Pan B, Wang W, Zhong P, Blankman J, Cravatt B, Liu Q
J Neurosci. 2011; 31(38):13420-30.
PMID: 21940435
PMC: 3371386.
DOI: 10.1523/JNEUROSCI.2075-11.2011.
Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning.
Liu Z, Han J, Jia L, Maillet J, Bai G, Xu L
PLoS One. 2010; 5(12):e15634.
PMID: 21187978
PMC: 3004941.
DOI: 10.1371/journal.pone.0015634.
Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure.
Goonawardena A, Robinson L, Riedel G, Hampson R
Hippocampus. 2009; 20(9):1083-94.
PMID: 19771586
PMC: 2891278.
DOI: 10.1002/hipo.20706.
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Robinson L, Goonawardena A, Pertwee R, Hampson R, Riedel G
Br J Pharmacol. 2007; 151(5):688-700.
PMID: 17502849
PMC: 2013991.
DOI: 10.1038/sj.bjp.0707273.
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?.
Solowij N, Michie P
J Psychiatry Neurosci. 2007; 32(1):30-52.
PMID: 17245472
PMC: 1764544.
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman A, Oz M, Yang R, Lichtman A, Lupica C
Learn Mem. 2007; 14(1-2):63-74.
PMID: 17202425
PMC: 1828281.
DOI: 10.1101/lm.439007.
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.
Hill M, Froese L, Morrish A, Sun J, Floresco S
Psychopharmacology (Berl). 2006; 187(2):245-59.
PMID: 16752140
DOI: 10.1007/s00213-006-0421-4.
Identification of a high-affinity binding site involved in the transport of endocannabinoids.
Moore S, Nomikos G, Dickason-Chesterfield A, Schober D, Schaus J, Ying B
Proc Natl Acad Sci U S A. 2005; 102(49):17852-7.
PMID: 16314570
PMC: 1295594.
DOI: 10.1073/pnas.0507470102.